The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Carcinoembryonic antigen (CEA) is not normally produced in significant quantities after birth
but is elevated in colorectal cancer. The aim of this review was to define the current role of …

The incidence of rectal cancer in the European Union is $125 000 per year, ie $35% of the
total colorectal cancer incidence, reflecting 15–25 cases/100000 population per year and is …

The number of cancer survivors continues to increase because of both advances in early
detection and treatment and the aging and growth of the population. For the public health …

Background Radical surgery via total mesorectal excision might not be the optimal first-line
treatment for early-stage rectal cancer. An organ-preserving strategy with selective total …

Aim Lung metastases from colorectal cancer are resected in selected patients in the belief
that this confers a significant survival advantage. It is generally assumed that the 5‐year …

Importance Guidelines recommend measuring preoperative carcinoembryonic antigen
(CEA) in patients with colon cancer. Although persistently elevated CEA after surgery has …

Objective: The study aims to investigate the prognostic value of the lymphocyte-to-monocyte
ratio (LMR) in patients with colorectal cancer (CRC) undergoing curative resection and to …

Treatments for colorectal cancer (CRC) of all stages have evolved considerably over the
past two decades, resulting in improved long-term outcomes. After curative treatment …

Importance Intensive follow-up of patients after curative surgery for colorectal cancer is
common in clinical practice, but evidence of a survival benefit is limited. Objective To …